About this trial
Collecting data using Kera Sol tear usage during the initial two-week post-operative period after Laser-Assisted In Situ Keratomileusis (LASIK) has on the signs and symptoms of surgical temporary ocular discomfort syndrome (STODS)
Eligibility criteria
Qualifiers
Be willing and able to sign the informed consent form (ICF)
Be at least 18 years of age at the screening visit
Be undergoing LASIK treatment in both eyes
Be literate and able to complete questionnaires independently
Disqualifiers
Use of topical prescription dry eye medications such as lifitegrast, cyclosporine, loltilaner, etc.
Have a break in the integrity of the corneal epithelium such as a persistent corneal epithelial defect, or corneal ulcer.
Have presence of corneal pathology that may interfere with LASIK outcomes
Active infectious, ocular or systemic disease
Trial design
Treatments tested in this trial
- Kera Sol Eye Drops